Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Debt to Equity (2016 - 2022)

Nephros has reported Debt to Equity over the past 9 years, most recently at $0.02 for Q4 2022.

  • Quarterly results put Debt to Equity at $0.02 for Q4 2022, down 17.21% from a year ago — trailing twelve months through Dec 2022 was $0.02 (down 17.21% YoY), and the annual figure for FY2022 was $0.02, down 17.21%.
  • Debt to Equity for Q4 2022 was $0.02 at Nephros, up from $0.01 in the prior quarter.
  • Over the last five years, Debt to Equity for NEPH hit a ceiling of $0.63 in Q1 2018 and a floor of $0.01 in Q3 2022.
  • Median Debt to Equity over the past 5 years was $0.04 (2020), compared with a mean of $0.12.
  • Biggest five-year swings in Debt to Equity: tumbled 92.31% in 2018 and later increased 4.78% in 2022.
  • Nephros' Debt to Equity stood at $0.27 in 2018, then crashed by 55.99% to $0.12 in 2019, then plummeted by 61.55% to $0.05 in 2020, then plummeted by 49.06% to $0.02 in 2021, then fell by 17.21% to $0.02 in 2022.
  • The last three reported values for Debt to Equity were $0.02 (Q4 2022), $0.01 (Q3 2022), and $0.03 (Q2 2022) per Business Quant data.